FDA Approves Elevidys with Stricter Labeling
Update: 2025-11-14
Description
Sarepta Therapeutics Elevidys gene therapy receives FDA approval with restricted use, following reports of fatal liver failures in non-ambulatory patients. The updated labeling includes a Boxed Warning, weekly liver function tests, and a study to further investigate liver injury risks.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
